Emergent BioSolutions Analyst Price Targets

Wall Street analyst price targets and consensus rating for Emergent BioSolutions (EBS).

Price Target Range — 10 Quarters

Analyst Consensus — 4 Analysts

3Buy

1Sell

Consensus RatingBuy# Analysts4Avg. Consensus PT$14Upside to Avg. PT+95.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 9, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$10
Aug 21, 2026	JP Morgan	Jessica Fye	Reinstates	Underweight	—
Aug 10, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$12→$10
Mar 9, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$15→$12
Dec 16, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$15
Sep 3, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$15
Apr 1, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$15
Mar 21, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$15
Mar 4, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$15
Jan 21, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$15
Jan 10, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$15
Dec 30, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Initiate	Buy	$15
Nov 7, 2024	Benchmark	Robert Wasserman	PT Raise	Buy	$8→$12
Sep 13, 2024	Rodman & Renshaw	Brandon Folkes	Maintained	Buy	$16
Aug 22, 2024	Rodman & Renshaw	—	Initiate	Buy	$16
Aug 16, 2024	Benchmark	Robert Wasserman	Maintained	Buy	$8
Aug 9, 2024	Benchmark	Robert Wasserman	Maintained	Buy	$8
Jul 3, 2024	Benchmark	Robert Wasserman	Maintained	Buy	$8
Jul 2, 2024	Benchmark	Robert Wasserman	Maintained	Buy	$8
Jun 24, 2024	Benchmark	Robert Wasserman	Maintained	Buy	$8

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $10 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
JP Morgan Reinstates Underweight on Emergent BioSolutions

JP Morgan analyst Jessica Fye reinstates Emergent BioSolutions (NYSE:EBS) with a Underweight.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $10

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Emergent BioSolutions (NYSE:EBS) with a Buy and lowers the price target from $12 to $10.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Emergent BioSolutions (NYSE:EBS) with a Buy and lowers the price target from $15 to $12.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $15 price target.

Benzinga Newsdesk

Emergent BioSolutions Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Emergent BioSolutions Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $10 Price Target

PRO
JP Morgan Reinstates Underweight on Emergent BioSolutions

PRO
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $10

PRO
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $12

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

People Also Watch

People Also Watch

Emergent BioSolutions Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Emergent BioSolutions Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $10 Price Target

PROJP Morgan Reinstates Underweight on Emergent BioSolutions

PROHC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $10

PROHC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $12

PROHC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

PROHC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $10 Price Target

PRO
JP Morgan Reinstates Underweight on Emergent BioSolutions

PRO
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $10

PRO
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $12

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target